Anti-inflammatory function of secretory leukocyte protease inhibitor

Journal of Endotoxin Research

Volumn 5, Issue 3, 1999, Pages 167-169

  Ding, Aihao ^a   Zhu, Jing ^a   Jin, Fenyu ^a   Grobmyer, Stephen R ^a   Nathan, Carl F ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; BACTERIUM LIPOPOLYSACCHARIDE; COMPLEMENTARY DNA; INTERLEUKIN 10; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; NITRIC OXIDE; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; SERINE PROTEINASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENETIC TRANSCRIPTION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; MACROPHAGE; MOLECULAR CLONING; NORMAL HUMAN; PHAGOCYTE; SEQUENCE HOMOLOGY;

BACTERIA (MICROORGANISMS); NEGIBACTERIA; POSIBACTERIA;

EID: 0032845984     PISSN: 09680519     EISSN: None     Source Type: Journal    
DOI: 10.1179/096805199101531697     Document Type: Conference Paper

References (13)

1. Sultzer BM. Genetic control of leucocyte responses to endotoxin. Nature 1968; 219: 1253-1254.
2. Watson J, Largen M, McAdam KP. Genetic control of endotoxic responses in mice. J Exp Med 1978; 147: 39-49.
3. Liang P, Pardee AB. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 1992; 257: 967-971.
4. Jin FY, Nathan C, Radzioch D, Ding A. Secretory leukocyte protease inhibitor: a macrophage product induced by and antagonistic to bacterial lipopolysaccharide. Cell 1997; 88: 417-426.
5. Thompson RC, Ohlsson K. Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase. Proc Natl Acad Sci USA 1986; 83: 6692-6696.
6. Fink E, Nettelbeck R, Fritz H. Inhibition of mast cell chymase by eglin c and antileukoprotease (HUSI-I). Indications for potential biological functions of these inhibitors. Biol Chem Hoppe Seyler 1986; 367: 567-571.
7. Ohlsson K, Bergenfeldt M, Bjork P. Functional studies of human secretory leukocyte protease inhibitor. Adv Exp Med Biol 1988; 240:123-131.
8. Hiemstra PS, Maassen RJ, Stolk J, Heinzel-Wieland R, Steffens GJ, Dijkman JH. Antibacterial activity of antileukoprotease. Infect Immun 1996; 64: 4520-4524.
9. McNeely TB, Dealy M, Dripps DJ, Orenstein JM, Eisenberg SP, Wahl SM. Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro. J Clin Invest 1995; 96: 456-464.
10. Abe T, Kobayashi N, Yoshimura K et al. Expression of the secretory leukoprotease inhibitor gene in epithelial cells. J Clin Invest 1991; 87: 2207-2215.
11. Bohm B, Aigner T, Kinne R, Burkhardt H. The serine-protease inhibitor of cartilage matrix is not a chondrocytic gene product. Eur J Biochem 1992; 207: 773-779.
12. Jin FY, Nathan CF, Radzioch D, Ding A. Lipopolysaccharide-related stimuli induce expression of the secretory leukocyte protease inhibitor, a macrophage-derived lipopolysaccharide inhibitor. Infect Immun 1998; 66:2447-2452.
13. Marshall JC, Cook DJ, Christou NV, Bernard GR, Sprung CL, Sibbald WJ. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med 1995; 23:1638-1652.